We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8136:TSESanrio Co. Ltd. Analysis

Data as of 2026-06-18 - not real-time

HK$0.04

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

IMS Group is trading near its short‑term moving average and has slipped below the 20‑day SMA, signalling a bearish technical bias. The 14‑day RSI is in oversold territory, suggesting limited upside momentum in the near term. MACD remains bearish with the histogram below zero, reinforcing the downtrend. Volume is rising, but the price is trapped between a clear support level and a modest resistance ceiling, limiting breakout potential. Market sentiment is at an extreme greed phase, which can exacerbate short‑term price swings. On the fundamentals side, the company carries a very low price‑to‑earnings multiple compared with its industry peers, and its price‑to‑book and price‑to‑sales ratios are also well below sector averages. Despite the attractive valuation, revenue is contracting, free cash flow is negative, and earnings are modest, indicating that the upside may be limited unless a turnaround materialises.
Overall, the stock appears deeply undervalued relative to its discounted cash‑flow estimate, but the combination of bearish technical signals, high recent volatility, and weak growth fundamentals creates a cautious outlook. The balance sheet is strong with ample cash and minimal debt, which provides a cushion and could support a longer‑term recovery if operational performance improves. Investors should weigh the attractive valuation against the current earnings weakness and elevated risk profile before deciding on exposure.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in oversold range
  • Bearish MACD alignment
  • Price testing immediate support

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Deep valuation discount
  • Weak revenue growth
  • Strong cash position

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value far above market price
  • Low valuation multiples versus industry
  • Balance sheet resilience with minimal debt

Key Metrics & Analysis

Financial Health

Revenue Growth-23.50%
Profit Margin10.28%
P/E Ratio4.0
ROE5.64%
ROA2.77%
Debt/Equity2.78
P/B Ratio0.4
Op. Cash FlowHK$5.8M
Free Cash FlowHK$-6526375
Industry P/E31.2

Technical Analysis

TrendBearish
RSI31.5
SupportHK$0.04
ResistanceHK$0.04
MA 20HK$0.04
MA 50HK$0.04
MA 200HK$0.04
MACDBearish
VolumeIncreasing
Fear & Greed Index88.5

Valuation

Fair ValueHK$0.14
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.30
Volatility53.92%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.